Screener
NeoGenomics NEO Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | (unaudited)June 30, 2026 | December 31, 2025 |
|---|---|---|
| Goodwill | 523,995 | 524,344 |
| Other assets | 9,311 | 9,340 |
| Total non-current assets | 970,765 | 983,544 |
| Total assets | $1,352,243 | $1,359,830 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Accounts payable | $20,953 | $23,090 |
| Accrued compensation | 56,265 | 47,580 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's total assets?
- NeoGenomics (NEO) reported total assets of $1.35B in Q2 2026.
- How has NeoGenomics's total assets changed year-over-year?
- NeoGenomics's total assets decreased by 3.0% year-over-year, from $1.39B to $1.35B.
- What is the long-term trend for NeoGenomics's total assets?
- Over 5 years (2020 to 2025), NeoGenomics's total assets has grown at a 6.6% compound annual growth rate (CAGR), from $988.33M to $1.36B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about NeoGenomics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude